MedTrace Logo

The Effects of Escitalopram on Cytokines

NCT01587326 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2012-05-15

No results posted yet for this study

Summary

The association of cytokines with escitalopram has not been investigated in patients with major depressive disorder (MDD). Hence, the investigators will examine this association.

Conditions

Interventions

DRUG

Escitalopram

escitalopram 10 mg/d to 20 mg/d

Sponsors & Collaborators

  • Beitou Armed Forces Hospital, Taipei, Taiwan

    lead OTHER_GOV

Principal Investigators

  • Peishen Ho, M.D. · Beitou Armed Forces Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01587326 on ClinicalTrials.gov